Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.8900 (4.39%) ($6.8900 - $6.8900) on Thu. Feb. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.13% (three month average) | RSI | 70 | Latest Price | $6.8900(4.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SMH(59%) SPY(59%) JNK(58%) ARKG(57%) PAVE(56%) | Factors Impacting CAPR price | CAPR will decline at least -3.565% in a week (0% probabilities). XRT(-27%) VIXM(-68%) TBT(-11%) UUP(-9%) USO(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.565% (StdDev 7.13%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.6(4.39%) | 10 Day Moving Average | $6.49(6.16%) | 20 Day Moving Average | $5.69(21.09%) | To recent high | -10.7% | To recent low | 31.2% | Market Cap | $136m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |